about
Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectinAdipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cellIdentification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signalingThe FTO genotype as a useful predictor of body weight maintenance: initial data from a 5-year follow-up study.Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation.Genetic variations in the CYP17A1 and NT5C2 genes are associated with a reduction in visceral and subcutaneous fat areas in Japanese women.Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population.Functional single-nucleotide polymorphisms in the secretogranin III (SCG3) gene that form secretory granules with appetite-related neuropeptides are associated with obesity.Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population.INSIG2 gene rs7566605 polymorphism is associated with severe obesity in Japanese.Life style-related diseases of the digestive system: gene expression in nonalcoholic steatohepatitis patients and treatment strategies.Secretogranin II binds to secretogranin III and forms secretory granules with orexin, neuropeptide Y, and POMC.Identification of core gene networks and hub genes associated with progression of non-alcoholic fatty liver disease by RNA sequencing.Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus.Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease.Polymorphisms in NRXN3, TFAP2B, MSRA, LYPLAL1, FTO and MC4R and their effect on visceral fat area in the Japanese population.The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease.Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance.Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.Screening of 336 single-nucleotide polymorphisms in 85 obesity-related genes revealed McKusick-Kaufman syndrome gene variants are associated with metabolic syndrome.[New insights about obesity-related genes].Identification of the genomic region under epigenetic regulation during non-alcoholic fatty liver disease progression.Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999.CDH13 Polymorphisms are Associated with Adiponectin Levels and Metabolic Syndrome Traits Independently of Visceral Fat Mass.ADIPOQ polymorphisms are associated with insulin resistance in Japanese women.Association of single-nucleotide polymorphisms in MTMR9 gene with obesity.Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease.Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation.NUDT3 rs206936 is associated with body mass index in obese Japanese women.Genomic structure and mutations in adipose-specific gene, adiponectinAssociation between type 2 diabetes genetic susceptibility loci and visceral and subcutaneous fat area as determined by computed tomographyAssociation of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese populationComputed tomography analysis of the association between the SH2B1 rs7498665 single-nucleotide polymorphism and visceral fat areaIdentification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver diseaseCharacteristics of non-obese non-alcoholic fatty liver disease: Effect of genetic and environmental factorsFTO gene variant and risk of hypertension: A meta-analysis of 57,464 hypertensive cases and 41,256 controlsTargeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver diseaseAssociation of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits
P50
Q22010955-D0815F32-C737-408F-BC5A-883E20A4D511Q24299893-DB85C59E-9823-4F44-AED8-42EE5892E140Q24644273-4DEDB6C1-CE19-48E3-8D3D-DFAF4D711806Q30814645-955B76CA-459A-476E-A609-6FB1F9DBE595Q33347569-9D670311-9BA4-47C2-B9A8-84A05E099184Q33991014-BAAA6D49-B47F-4348-912C-112873484A45Q34231237-B47BE505-8A0A-4671-A5BE-F169C446273DQ34271316-ADC0954A-82BE-41CA-994E-C30DAE32478DQ34597009-BAFE87A2-53B3-41AA-8B51-3EC87E053F3BQ35009189-45520768-B589-4DA5-9F28-F6D9B74599AFQ36848982-AA483976-2194-45E6-8118-4C2D3496E84EQ36967717-3CDBE0DE-9554-473F-A3EC-BBA3A1ECF7FAQ38355183-A388FDB0-C614-4F18-AAFF-80DE7E4685FCQ38951594-5ABF8F5D-0189-4309-B744-B2AD409FE2B9Q40765316-5829D061-0E0F-4EC4-8B4E-EC403CD267FDQ41428198-F76858E8-3F8A-4A24-BE98-E04626528795Q42940080-4295C25B-6E8B-47A4-A709-393F19CA8F1EQ43668487-402B5836-8A1D-4FE3-99BF-826909B35DB6Q43809017-FE32B6C6-7989-4F7B-8589-1EB557DCE219Q44030028-084D3788-698F-42AF-BC53-E8F41D705C45Q44629405-67A45BD4-2CCE-4E16-B445-C050F81D4B98Q46128564-DF3A42D3-D2FC-480F-B2AD-F6C2464E31FAQ47615586-9C0D1A53-ABB2-4827-B718-D22B8C575117Q48396083-9C515E61-CE87-4C2B-A3FA-A651F52C1DF1Q51296264-7A033C69-5D0B-449C-ADA4-E19550374CD8Q51305424-7B3D630E-BEA0-47B6-80D9-27DF3FAD9B3AQ51463472-5C23590A-4E73-48F0-AED5-94D056833F82Q51555890-1C30C1A1-9CDB-4B39-AC3F-6FC672F4477FQ51757427-013A7353-7062-4AC1-9AF4-B0F607FA9E41Q51780465-2674C273-15E4-4111-B2C8-BF8BC147D176Q53108028-9AB6FF3F-69EB-49AB-A4AB-FD3E0CEC8B61Q55670912-EDE68031-9A13-482C-B88B-92C31651F05FQ58366314-CB5AF3C8-8A07-4EE7-A59F-B96A83090E7DQ58366438-4AE80935-3972-420E-A9D5-6D77CEED6CA7Q58366440-39B931C1-A643-4E7A-9D8C-ECDE6EDDBB0BQ58751826-9313EE97-5C0D-4B7C-B16B-7AD429E506D5Q60507076-12AFBB03-AE24-435E-A155-B17B6D646584Q60507081-2AC1B960-7F01-42EC-A704-0637CC805EAAQ60507082-40F05B08-CA91-4851-96EC-DD130CE6BC1FQ60507083-C038EDEB-46A1-4213-81F0-7AB9D9609D4A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kikuko Hotta
@ast
Kikuko Hotta
@en
Kikuko Hotta
@es
Kikuko Hotta
@nl
Kikuko Hotta
@sl
type
label
Kikuko Hotta
@ast
Kikuko Hotta
@en
Kikuko Hotta
@es
Kikuko Hotta
@nl
Kikuko Hotta
@sl
prefLabel
Kikuko Hotta
@ast
Kikuko Hotta
@en
Kikuko Hotta
@es
Kikuko Hotta
@nl
Kikuko Hotta
@sl
P106
P21
P31
P496
0000-0003-2427-6354
P569
2000-01-01T00:00:00Z